The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Not Applicable

Recruiting

• Conditions: HPV Infection

• Registration Number: NCT06285357
• Lead Sponsor: Lo.Li.Pharma s.r.l

Brief Summary

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-19
• Study First Submitted: 2024-02-22
• Study First Submitted QC: 2024-02-28
• Study First Posted: 2024-02-29
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-06
• Last Update Posted: 2025-03-07
• Primary Completion: 2025-09
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• HR-HPV DNA test positivity

Exclusion Criteria

• No HSIL

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
HPV DNA test negativity	8 months of treatment	Percentage

Trial Locations

Locations (1)

Azienda Ospedaliero-Universitaria di Modena; 🇮🇹 Modena, Italy